These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 365748)

  • 1. Activation of the alternative complement pathway by a streptococcal lipoteichoic acid.
    Fiedel BA; Jackson RW
    Infect Immun; 1978 Oct; 22(1):286-7. PubMed ID: 365748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nephropathy in the rabbit associated with immunization to a group A stretococcal lipoteichoic acid.
    Fiedel BA; Jackson RW
    Med Microbiol Immunol; 1979; 167(4):251-60. PubMed ID: 397407
    [No Abstract]   [Full Text] [Related]  

  • 3. The ability to sensitize host cells for destruction by autologous complement is a general property of lipoteichoic acid.
    Weinreb BD; Shockman GD; Beachey EH; Swift AJ; Winkelstein JA
    Infect Immun; 1986 Nov; 54(2):494-9. PubMed ID: 3533782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenesis of rheumatic fever: a review.
    Rotta J
    Ann Trop Paediatr; 1983 Mar; 3(1):1-8. PubMed ID: 6191642
    [No Abstract]   [Full Text] [Related]  

  • 5. Monoclonal antibodies to immunodeterminants of lipoteichoic acids.
    Jackson DE; Wong W; Largen MT; Shockman GD
    Infect Immun; 1984 Mar; 43(3):800-3. PubMed ID: 6199301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of antibody to staphylococcal lipoteichoic acid with a microenzyme-linked immunosorbent assay.
    Carruthers MM; Jenkins KE; Kabat WJ; Buranosky T
    J Clin Microbiol; 1984 Apr; 19(4):552-4. PubMed ID: 6715523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of the alternative complement pathway by pneumococcal lipoteichoic acid.
    Hummell DS; Swift AJ; Tomasz A; Winkelstein JA
    Infect Immun; 1985 Feb; 47(2):384-7. PubMed ID: 3881346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemical properties and immunobiological activities of streptococcal lipoteichoic acids.
    Hamada S; Yamamoto T; Koga T; McGhee JR; Michalek SM; Yamamoto S
    Zentralbl Bakteriol Mikrobiol Hyg A; 1985 Apr; 259(2):228-43. PubMed ID: 3892980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Humoral and cellular immune responses to staphylococcal lipoteichoic acid in multiple sclerosis patients.
    Nyland H; Aasjord P
    Prog Brain Res; 1983; 59():345-54. PubMed ID: 6607483
    [No Abstract]   [Full Text] [Related]  

  • 10. The properties of a lipoteichoic acid antigen from Streptococcus pyogenes.
    Rudczynski AB; Jackson RW
    Immunochemistry; 1978 Feb; 15(2):83-91. PubMed ID: 344195
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunogenicity of a purified and carrier-complexed streptococcal lipoteichoic acid.
    Fiedel BA; Jackson RW
    Infect Immun; 1976 Jun; 13(6):1585-90. PubMed ID: 786876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Preparation of immune sera to group A streptococcus lipoteichoic acid].
    Dmitrieva NF; Vylegzhanina ES; Grabovskaia KB; Totolian AA; Blinnikova EI; Briko NI
    Lab Delo; 1990; (11):72-4. PubMed ID: 1704969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Lipoteichoic acid in beta hemolytic streptococci].
    Bícová R
    Cesk Epidemiol Mikrobiol Imunol; 1985 Sep; 34(5):310-9. PubMed ID: 2932231
    [No Abstract]   [Full Text] [Related]  

  • 14. Encephalitis induced in rabbits by staphylococcal lipoteichoic acid.
    Aasjord P; Nyland H; Mørk S
    Acta Pathol Microbiol Scand C; 1980 Dec; 88(6):287-91. PubMed ID: 7246143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell structure and antigenic composition of GBS.
    Kasper DL; Baker CJ; Jennings HJ
    Antibiot Chemother (1971); 1985; 35():90-100. PubMed ID: 3901913
    [No Abstract]   [Full Text] [Related]  

  • 16. Release of fibronectin-lipoteichoic acid complexes from group A streptococci with penicillin.
    Nealon TJ; Beachey EH; Courtney HS; Simpson WA
    Infect Immun; 1986 Feb; 51(2):529-35. PubMed ID: 3510980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of a monoclonal antibody specific for lipoteichoic acid from various gram-positive bacteria.
    Hamada S; Furuta T; Okahashi N; Nisizawa T; Yamamoto T; Chiba J
    Microbiol Immunol; 1984; 28(9):1009-21. PubMed ID: 6083437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased serum IgG antibodies reactive with lipoteichoic acids in subjects with gingivitis.
    Monefeldt K; Tollefsen T; Assev S; Rølla G
    J Periodontal Res; 1987 Mar; 22(2):114-8. PubMed ID: 2953881
    [No Abstract]   [Full Text] [Related]  

  • 19. Interaction of purified lipoteichoic acid with the classical complement pathway.
    Loos M; Clas F; Fischer W
    Infect Immun; 1986 Sep; 53(3):595-9. PubMed ID: 3488963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunochemical studies on the lipoteichoic acids of Bifidobacterium bifidum subsp. pennsylvanicum.
    Op den Camp HJ; Peeters PA; Oosterhof A; Veerkamp JH
    J Gen Microbiol; 1985 Mar; 131(3):661-8. PubMed ID: 2410545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.